Skip to main content
. 2022 Nov 25;2022:7752277. doi: 10.1155/2022/7752277

Figure 3.

Figure 3

miR-210 promotes tumor angiogenesis, cell invasion, and proliferation in HUVECs. (a–b) The angiogenesis abilities of the indicated treated HUVECs measured by tube formation assays. Scale bars = 50 μm. (c–d) The invasion abilities of HUVECs were measured by transwell assays. Scale bars = 50 μm. (e–f) The proliferation abilities of the indicated treated HUVECs were measured by EdU assays. Magnification, ×200.